12:00 AM
 | 
Feb 03, 2003
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Novuspharma S.p.A.

(NMerc:NOV), Monza, Italy

Business: Cancer

Lehman Brothers analyst Ed Godber lowered his rating to "equal...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >